Editorial

Nuclear Medicine Communications

Volumn 24, Issue 2, 2003, Pages 111-113

  Coakley, A J ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

CLINICAL PRACTICE; COMPUTER ASSISTED SURGERY; CONSENSUS DEVELOPMENT; HUMAN; HYPERPARATHYROIDISM; METHODOLOGY; NOTE; PARATHYROID GLAND; PARATHYROIDECTOMY; PATIENT CARE; PREOPERATIVE CARE; SCINTISCANNING;

CONSENSUS DEVELOPMENT CONFERENCES; HUMANS; HYPERPARATHYROIDISM; PARATHYROID GLANDS; PARATHYROIDECTOMY; PATIENT CARE MANAGEMENT; PHYSICIAN'S PRACTICE PATTERNS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; SURGERY, COMPUTER-ASSISTED; TECHNETIUM TC 99M SESTAMIBI;

EID: 85047278197     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200302000-00001     Document Type: Article

References (18)

1. Consensus development conference panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement. Ann Intern Med 1991; 114: 593-597.
2. Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 2002; 137: 1055-1059.
3. 99mTc-sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794.
4. 99mTc-MIBI radio-guided minimally invasive parathyroidectomy: experience with patients with normal thyroids and nodular goiters. Thyroid 2002; 12: 53-61.
5. Denham DW, Norman J. Cost effectiveness of preoperative sestamibi scans for primary hyperparathyroidism is dependent solely upon the surgeon’s choice of operative procedure. J Am Coll Surg 1998; 186: 293-305.
6. 99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997; 169: 1671-1674.
7. Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium 99m pertechnetate/sestamibi subtraction, a double phase technetium 99m sestamibi and technetium 99m sestamibi SPECT. J Nucl Med 1997; 38: 834-839.
8. Ceyssens S, Mortelmans L. Parathyroid imaging: MIBI-dual phase versus MIBI/I123 subtraction. Acta Otorhinolaryngol Belg 2001; 55: 103-117.
9. 99mTc-sestamibi scintigraphy: Dual-tracer subtraction is superior to double-phase washout. Eur J Nucl Med 2002; 29: 1566-1570.
10. Arveschoug AK, Bertelsen H, Vammen B. Presurgical localization of abnormal parathyroid glands using a single injection of Tc-99m sestamibi comparison of high-resolution parallel hole and pinhole collimators, and interobserver and intraobserver variation. Clin Nucl Med 2002; 27: 249-254.
11. Moka D, Voth E, Dietlein M, Larena-Avellanda A, Schicha H. Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000; 128: 29-35.
12. Lumachi F, Ermani M, Basso S, Zuchetta P, Borsato N, Favia G. Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection. Endocrine-Related Cancer 2001; 8: 63-69.
13. Kao A, Yu- CS, Shih-Chuan T, et al. Technetium-99m MIBI imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med 2002; 29: 1012-1015.
14. Yamaguchi S, Yachiku S, Hashimoto H, et al. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. World J Surg 2002; 26: 29-34.
15. Okamura T. Imaging the parathyrod glands using 99mTc-tetrofosmin: current status. Internal Medicine 2000; 39: 85-86.
16. Froberg AC, Valkema R, Bonjer HJ, Krenning EP. 99m Technetium-tetrofosmin or 99m technetium-sestamibi for double-phase parathyroid scintigraphy. Eur J Nucl Med 2003; DOI 10.1007/s00259-002-1030-z.
17. 11C-methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 1998; 139: 195-197.
18. Fahy BN, Bold RJ, Beckett L, Schneider PD. Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg 2002; 137: 917-922.